Swedish Orphan Biovitrum AB
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Swedish Orphan Biovitrum AB in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Swedish Orphan Biovitrum AB.
Recent articles on PMLiVE featuring Swedish Orphan Biovitrum AB
The deal marks a notable expansion to the Swedish drugmaker’s rare haematology pipeline
Phase 3 results showed once-weekly doses provided clinically meaningful bleed protection for patients with haemophilia A
Results from the study showed once-weekly efanesoctocog alfa doses provided ‘clinically meaningful’ bleed protection for patients with severe haemophilia A
Hopes to boost haematology franchise with lead drug Doptelet
Looking to M&A for continued growth
Positive top-line data triggered speedy assessments
Approval adds to growing US portfolio
AZ continues sell-off, SOBI spies US expansion
Wills Hughes-Wilson joins the group from Sobi
The CHMP’s positive opinion could see the drug return to market after almost eight years
He joins the rare disease pharma firm from BSN Medical
Plans to launch the haemophilia B treatment in the fourth quarter
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology